Brind.
  1. NeOnc Technologies Holdings, Inc. announced strategic partnerships, board appointments, and acquisitions to advance its drug discovery engine.

Josh Neman was appointed Chief Clinical Officer at NeOnc Technologies Holdings, Inc.

2 reports, 1 independent Updated Nov 2
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Josh Neman was appointed Chief Clinical Officer at NeOnc Technologies Holdings, Inc.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Josh Neman is affiliated with USC, and NeOnc presented data in Philadelphia.1 source
  2. Josh Neman joins NeOnc Technologies Holdings, Inc. as Chief Clinical Officer.1 source

Keep exploring

The entities involved

  • Josh Neman

    researcher (ORCID 0000-0002-6337-9615)

    Nothing else this week.

Coverage

Newest first; wire copies grouped